Ambry Genetics Advances Patient Care through Telemedicine Genetic Counseling Services & PWNHealth Partnership
Ambry Genetics
1 Enterprise
Aliso Viejo, CA 92656
Aliso Viejo, CA (October 17, 2017): Ambry Genetics (Ambry), a leading clinical genetics-testing lab, announced today that they would be collaborating with PWNHealth to offer telemedicine genetic counseling as part of Ambry’s commitment to improve access to patient care.
Due to the rapid growth of genetic testing, the need for telemedicine genetic counseling services is expanding. PWNHealth provides these services through phone or video conferencing, thereby facilitating timely and convenient access to experienced genetic counselors.
Ambry employs more than 100 genetic counselors and has been providing physician support for nearly 20 years, as part of their hereditary genetic testing portfolio of services. A genetic counselor plays a key role to help determine test appropriateness and results interpretation for healthcare providers and to their patients. Because certain payors require upfront genetic counseling services through an independent third party provider, PWNHealth can help patients understand risks and identify appropriate genetic testing options.
“We are very excited to partner with PWNHealth. Their genetic counseling service augments our comprehensive product portfolio nicely and gives clinicians a much-needed hand to identify hereditary risk in under-served patients and help guide their medical care,” stated Brigette Tippin Davis, Ph.D., FACMG, Amby’s Vice President of Research & Development.
PWNHealth is a virtual care company that enables access to diagnostic testing, treatment and professional guidance that empowers individuals to improve their health. Using our physicians and genetic counselors, robust technology platform and patient services center we provide services nationwide to a broad range of health industry customers. PWN was formed with private equity backing through the acquisition of Medivo’s Clinical Services Division and Bind Health. For more information, please visit www.pwnhealth.com.
Ambry Genetics, a subsidiary of REALM IDx, Inc., translates scientific research into clinically actionable test results based upon a deep understanding of the human genome and the biology behind genetic disease. It is a leader in genetic testing that aims to improve health by understanding the relationship between genetics and disease. Its unparalleled track record of discoveries over 25 years, and growing database that continues to expand in collaboration with academic, corporate and pharmaceutical partners, means Ambry Genetics is first to market with innovative products and comprehensive analysis that enable clinicians to confidently inform patient health decisions.
Media Contact
Mickie Henshall
Chief Marketing Officer
REALM IDx
mhenshall@realmidx.com